Naoko Seki

Kurume, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Corrigendum to "What prognostic factors have impacted the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic oral cancer?" [J Stomatol Oral Maxillofac Surg 125 (2024) 101961].

Corrigendum to "What prognostic factors have impacted the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic oral cancer?" [J Stomatol Oral Maxillofac Surg 125 (2024) 101961].

Journal: Journal of stomatology, oral and maxillofacial surgery

Published: May 16, 2025

What prognostic factors have impacted the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic oral cancer?

What prognostic factors have impacted the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic oral cancer?

Journal: Journal of stomatology, oral and maxillofacial surgery

Published: June 03, 2024

Pulmonary Tuberculosis Following Immune Checkpoint Inhibitor Treatment for Recurrent Maxillary Squamous Cell Carcinoma.

Pulmonary Tuberculosis Following Immune Checkpoint Inhibitor Treatment for Recurrent Maxillary Squamous Cell Carcinoma.

Journal: Cureus

Published: January 29, 2024

Prognostic effect of programmed cell death ligand 1/programmed cell death 1 expression in cancer stem cells of human oral squamous cell carcinoma.

Prognostic effect of programmed cell death ligand 1/programmed cell death 1 expression in cancer stem cells of human oral squamous cell carcinoma.

Journal: Oncology letters

Published: September 12, 2023

Adenosquamous Carcinoma in the Midline Dorsum of the Tongue: A Rare Case Report.

Adenosquamous Carcinoma in the Midline Dorsum of the Tongue: A Rare Case Report.

Journal: Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons

Published: April 05, 2018

Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer.

Predictive factors of the tumor immunological microenvironment for long-term follow-up in early stage breast cancer.

Journal: Cancer science

Published: September 09, 2016

CD44v3+/CD24- cells possess cancer stem cell-like properties in human oral squamous cell carcinoma.

CD44v3+/CD24- cells possess cancer stem cell-like properties in human oral squamous cell carcinoma.

Journal: International journal of oncology

Published: October 06, 2015

Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients.

Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients.

Journal: Breast cancer research : BCR

Published: October 08, 2013

Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy.

Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy.

Journal: Experimental and therapeutic medicine

Published: April 25, 2013

FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis.

FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis.

Journal: Molecular and clinical oncology

Published: September 27, 2012

Tricin inhibits proliferation of human hepatic stellate cells in vitro by blocking tyrosine phosphorylation of PDGF receptor and its signaling pathways.

Tricin inhibits proliferation of human hepatic stellate cells in vitro by blocking tyrosine phosphorylation of PDGF receptor and its signaling pathways.

Journal: Journal of cellular biochemistry

Published: February 24, 2012

Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways.

Bortezomib sensitizes human esophageal squamous cell carcinoma cells to TRAIL-mediated apoptosis via activation of both extrinsic and intrinsic apoptosis pathways.

Journal: Molecular cancer therapeutics

Published: June 03, 2010

Showing 1-12 of 12

Last Updated: 09/26/2026